摘要
背景:从真菌,苔藓,蕨类植物和开花植物中报道了二氢萜类化合物,一类不同于天然产物的天然产物,由连接芳香族部分的乙烯链中缺失的双键引起。 目的:本文综述了天然二氢白藜芦醇型二氢甾体类化合物的发生,结构和生物活性。 方法:Reaxys数据库搜索可能取代所有原子的二氢槲皮素衍生物,但不包括非天然产物和以乙基连接链为特征的额外环的化合物。 结果:结构包括简单的二氢白藜芦醇衍生物,由酰基部分和糖组成的复杂侧链取代的化合物,以及含有与二氢甾体单元连接的多环核心的化合物。二氢甾体具有广泛的生物活性,范围从期望的抗氧化剂和抗炎活性到有趣的神经保护和抗癌活性。特别是抗癌活性对于一些植物来源的二氢甾体非常明显,并且使它们成为用于药物开发的有趣的先导化合物。除了关于二氢白藜芦醇衍生物作为抗植物病原真菌的植物抗毒素的报道外,关于这些化合物对生产它们的生物的生态学作用的信息非常有限。 结论:二氢甾体是一类具有重要生物活性的天然产物;它们在植物和真菌的王国中分散但并非普遍存在的现象不容易解释。我们相信,未来的研究将确定二氢甾体类化合物的新来源,我们希望目前的审查将启发这些研究,并将有助于将这些努力引导至合适的来源生物体并朝着有希望的生物活性。
关键词: 生物活性,化学多样性,化学系统学,细胞毒性,系统发育,次生代谢物。
Current Medicinal Chemistry
Title:Dihydroresveratrol Type Dihydrostilbenoids: Chemical Diversity, Chemosystematics, and Bioactivity
Volume: 25 Issue: 10
关键词: 生物活性,化学多样性,化学系统学,细胞毒性,系统发育,次生代谢物。
摘要: Background: Dihydrostilbenoids, a diverse class of natural products differing from stilbenoids by the missing double bond in the ethylene chain linking the aromatic moieties, have been reported from fungi, mosses, ferns, and flowering plants.
Objective: Occurrence, structure, and bioactivity of naturally occurring dihydroresveratrol type dihydrostilbenoids are discussed in this review.
Method: A Reaxys database search for dihydroresveratrol derivatives with possible substitutions on all atoms, but excluding non-natural products and compounds featuring additional rings involving the ethyl connecting chain, was performed.
Results: Structures include simple dihydroresveratrol derivatives, compounds substituted with complex side chains composed of acyl moieties and sugars, and compounds containing polycyclic cores attached to dihydrostilbenoid units. Dihydrostilbenoids have a wide spectrum of bioactivities ranging from expectable antioxidant and anti-inflammatory activities to interesting neuroprotective and anticancer activity. The anticancer activity in particular is very pronounced for some plant-derived dihydrostilbenoids and makes them interesting lead compounds for drug development. Apart from some reports on dihydroresveratrol derivatives as phytoalexins against plant-pathogenic fungi, only very limited information is available on the ecological role of these compounds for the organisms producing them.
Conclusion: Dihydrostilbenoids are a class of natural products possessing significant biological activities; their scattered but not ubiquitous occurrence throughout the kingdoms of plants and fungi is not easily explained. We are convinced that future studies will identify new sources of dihydrostilbenoids, and we hope that the present review will inspire such studies and will help in directing such efforts to suitable source organisms and towards promising bioactivities.
Export Options
About this article
Cite this article as:
Dihydroresveratrol Type Dihydrostilbenoids: Chemical Diversity, Chemosystematics, and Bioactivity, Current Medicinal Chemistry 2018; 25 (10) . https://dx.doi.org/10.2174/0929867324666170830112343
DOI https://dx.doi.org/10.2174/0929867324666170830112343 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Drug Therapies for Fertility Preservation in Men Undergoing Chemotherapy: Clinical Relevance of Protector Agents
Current Medicinal Chemistry The Urokinase Receptor Interactome
Current Pharmaceutical Design Invasive aspergillosis: adjunctive combination therapy
Mini-Reviews in Medicinal Chemistry Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study (Supplementry Table)
Current Pharmacogenomics and Personalized Medicine Bridging the Gap Between Chemistry and Biotechnology - Large Molecules with Potential, How Could Biotechnology Complement Chemistry?
Current Organic Chemistry Can Dietary Antioxidants Reduce the Incidence of Brain Tumors?
Current Drug Metabolism Fc Receptor-Mediated Immune Responses: New Tools But Increased Complexity in HIV Prevention
Current HIV Research Emerging Immunotargets in Bladder Cancer
Current Drug Targets Anti-tumoral Properties of Endogenous Angiogenesis Inhibitors: A Case for Continued TIMP-2 Preclinical Development
Current Angiogenesis (Discontinued) Editorial [Hot topic: Target Therapy of Bone Metastases and Tumours (Guest Editors: M. Caraglia and D. Santini)]
Current Cancer Drug Targets Inducers of Heme Oxygenase-1
Current Pharmaceutical Design Prevention and Treatment of Bone Metastases
Current Pharmaceutical Design Contrast Echocardiography: An Update on Clinical Applications
Current Pharmaceutical Design Inflammation-Mediating Proteases: Structure, Function in (Patho) Physiology and Inhibition
Protein & Peptide Letters CXCR4-CXCL12-Dependent Inflammatory Network and Endothelial Progenitors
Current Medicinal Chemistry Tumor Suppression by DNA Base Excision Repair
Mini-Reviews in Medicinal Chemistry Convection Enhanced Drug Delivery of Novel Therapeutic Agents to Malignant Brain Tumors
Current Drug Delivery Dantrolene Potentiates the Antineoplastic Effect of Sorafenib in Hepatocellular Carcinoma via Targeting Ca<sup>+2</sup>/PI3K Signaling Pathway
Current Molecular Pharmacology Dual-Specificity MAP Kinase Phosphatases as Targets of Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Biologically Active 4-Thiazolidinones: A Review of QSAR Studies and QSAR Modeling of Antitumor Activity
Current Topics in Medicinal Chemistry